Context Therapeutics
(NASDAQ) CNTX
Context Therapeutics Financials at a Glance
Market Cap
$54.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$40.23M
EPS (TTM)
-$0.43
P/E Ratio
-1.39
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Price
$0.58
Volume
124,243
Open
$0.62
Price
$0.58
Volume
124,243
Open
$0.62
Previous Close
$0.58
Daily Range
$0.56 - $0.65
52-Week Range
$0.55 - $3.62
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Price
$0.58
Volume
124,243
Open
$0.62
Previous Close
$0.58
Daily Range
$0.56 - $0.65
52-Week Range
$0.55 - $3.62
Estimated Earnings Date
Aug 5, 2026
CNTX News
CNTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Context Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
15
CEO
Martin A. Lehr, MA
Website
www.contexttherapeutics.comHeadquarters
Philadelphia, PA 19103, US
CNTX Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-59.95%
Return on Capital
-65.53%
Return on Assets
-68.34%
Earnings Yield
-71.94%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$54.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
91.88M
Volume
124.24K
Avg. Volume
1.99M
Financials (TTM)
Gross Profit
-$40.17K
Operating Income
-$43.52M
EBITDA
-$40.18M
Operating Cash Flow
-$32.79M
Capital Expenditure
-$37.26K
Free Cash Flow
-$32.82M
Cash & ST Invst.
$54.53M
Total Debt
$282.42K
Context Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$36.11K
N/A
Gross Margin
0.00%
N/A
Market Cap
$54.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$3.65M
N/A
Employees
15
N/A
Net Income
-$8.68M
-89.6%
EBITDA
-$8.64M
-89.0%
Quarterly Fundamentals
Total Cash
$54.53M
-39.0%
Total Debt
$282.42K
+45.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$122.37K
+48.1%
Short Term Debt
$160.06K
+44.1%
Return on Assets
-68.34%
N/A
Return on Invested Capital
-83.17%
N/A
Free Cash Flow
-$11.47M
-126.5%
Operating Cash Flow
-$11.43M
-127.3%